2-quinoxalinecarbonitrile: RN is from 9th CI, Chem Subs Index [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 593212 |
| SCHEMBL ID | 1999094 |
| MeSH ID | M0053607 |
| Synonym |
|---|
| 2-quinoxalinecarbonitrile |
| quinoxaline-2-carbonitrile |
| 7483-33-2 |
| AKOS006345812 |
| A9567 |
| FT-0682509 |
| SCHEMBL1999094 |
| DTXSID90225806 |
| mfcd12403337 |
| SY024819 |
| 2-cyanoquinoxaline |
| IVYZWJPQNNZOHV-UHFFFAOYSA-N |
| 2-quinoxalinecarbonitrile # |
| Z1201626498 |
| AC2537 |
| CS-11555 |
| AMY36712 |
| EN300-105607 |
| CS-0342963 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.30) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||